|
1
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian T, Wang M and Ma D: TNF-alpha, a good
or bad factor in hematological diseases? Stem Cell Investig.
1:122014.PubMed/NCBI
|
|
3
|
Jang DI, Lee AH, Shin HY, Song HR, Park
JH, Kang TB, Lee SR and Yang SH: the role of tumor necrosis factor
alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in
therapeutics. Int J Mol Sci. 22:27192021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams GM: Antitumor necrosis
factor-alpha therapy and potential cancer inhibition. Eur J Cancer
Prev. 17:169–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bryniarski P, Nazimek K and Marcinkiewicz
J: Immunomodulatory potential of diuretics. Biology (Basel).
10:13152021.PubMed/NCBI
|
|
6
|
Weinberg OK and Arber DA: How I diagnose
acute leukemia of ambiguous lineage. Am J Clin Pathol. 158:27–34.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Binder S, Luciano M and Horejs-Hoeck J:
The cytokine network in acute myeloid leukemia (AML): A focus on
pro- and anti-inflammatory mediators. Cytokine Growth Factor Rev.
43:8–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou X, Li Z and Zhou J: Tumor necrosis
factor α in the onset and progression of leukemia. Exp Hematol.
45:17–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoang T, Levy B, Onetto N, Haman A and
Rodriguez-Cimadevilla JC: Tumor necrosis factor alpha stimulates
the growth of the clonogenic cells of acute myeloblastic leukemia
in synergy with granulocyte/macrophage colony-stimulating factor. J
Exp Med. 170:15–26. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kagoya Y, Yoshimi A, Kataoka K, Nakagawa
M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y and Kurokawa
M: Positive feedback between NF-κB and TNF-α promotes
leukemia-initiating cell capacity. J Clin Invest. 124:528–542.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Verma S, Singh A, Yadav G, Kushwaha R, Ali
W, Verma SP and Singh US: Serum tumor necrosis factor-alpha levels
in acute leukemia and its prognostic significance. Cureus.
14:e248352022.PubMed/NCBI
|
|
12
|
Tuttolomondo A, Pinto A, Di Raimondo D,
Corrao S, Di Sciacca R, Scaglione R, Caruso C and Licata G: Changes
in natriuretic peptide and cytokine plasma levels in patients with
heart failure, after treatment with high dose of furosemide plus
hypertonic saline solution (HSS) and after a saline loading. Nutr
Metab Cardiovasc Dis. 21:372–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tuttolomondo A, Di Raimondo D, Bellia C,
Clemente G, Pecoraro R, Maida C, Simonetta I, Vassallo V, Di Bona
D, Gulotta E, et al: Immune-Inflammatory and metabolic effects of
high dose furosemide plus hypertonic saline solution (HSS)
treatment in cirrhotic subjects with refractory ascites. PLoS One.
11:e01654432016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu B, Thornton C, Makris A, Ogle R and
Hennessy A: Anti-hypertensive drugs alter cytokine production from
preeclamptic placentas and peripheral blood mononuclear cells.
Hypertens Pregnancy. 26:343–356. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu B, Makris A, Thornton C, Ogle R,
Horvath JS and Hennessy A: Antihypertensive drugs clonidine,
diazoxide, hydralazine and furosemide regulate the production of
cytokines by placentas and peripheral blood mononuclear cells in
normal pregnancy. J Hypertens. 24:915–922. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuengsrigul A, Chin TW and Nussbaum E:
Immunosuppressive and cytotoxic effects of furosemide on human
peripheral blood mononuclear cells. Ann Allergy Asthma Immunol.
83:559–566. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong QM, Ling C, Chen X and Zhao LI:
Inhibition of tumor necrosis factor-α enhances apoptosis induced by
nuclear factor-κB inhibition in leukemia cells. Oncol Lett.
10:3793–3798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou X, Zhou S, Li B, Li Q, Gao L, Li D,
Gong Q, Zhu L, Wang J, Wang N, et al: Transmembrane TNF-α
preferentially expressed by leukemia stem cells and blasts is a
potent target for antibody therapy. Blood. 126:1433–1442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Vilekar P, Huang J and Weaver DF:
Furosemide as a probe molecule for the treatment of
neuroinflammation in Alzheimer's disease. ACS Chem Neurosci.
11:4152–4168. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Wang Y, Vilekar P, Yang SP, Gupta
M, Oh MI, Meek A, Doyle L, Villar L, Brennecke A, et al: Small
molecule therapeutics for COVID-19: Repurposing of inhaled
furosemide. PeerJ. 8:e95332020. View Article : Google Scholar : PubMed/NCBI
|
